Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors

Sheeba Varghese, Thulani Senanayake, Tracy Murray Stewart, Kim Doering, Alison Fraser, Robert A Casero, Patrick M. Woster

Research output: Contribution to journalArticle

Abstract

A series of polyaminohydroxamic acids (PAHAs) and polyaminobenzamides (PABAs) were synthesized and evaluated as isoform-selective histone deacetylase (HDAC) inhibitors. These analogues contain a polyamine chain to increase affinity for chromatin and facilitate cellular import. Seven PAHAs inhibited HDAC >50% (1 μM), and two PABAs inhibited HDAC >50% (5 μM). Compound 17 increased acetylated α-tubulin in HCT116 colon tumor cells 253-fold but only modestly increased p21waf1 and acetylated histones 3 and 4, suggesting that 17 selectively inhibits HDAC 6. PABA 22 alone minimally increased p21waf1 and acetylated histones 3 and 4 but caused dose-dependent increases in p21waf1 in combination with 0.1 μM 5-azadeoxycytidine. Finally, 22 appeared to be a substrate for the polyamine transport system. None of these compounds were cytotoxic at 100 μM. PAHAs and PABAs exhibit strikingly different cellular effects from SAHA and have the potential for use in combination antitumor therapies with reduced toxicity.

Original languageEnglish (US)
Pages (from-to)2447-2456
Number of pages10
JournalJournal of Medicinal Chemistry
Volume51
Issue number8
DOIs
StatePublished - Apr 24 2008

Fingerprint

Histone Deacetylase Inhibitors
Histone Deacetylases
Protein Isoforms
decitabine
Polyamines
Histones
Acids
Tubulin
Chromatin
Toxicity
Tumors
Colon
Cells
Substrates
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors. / Varghese, Sheeba; Senanayake, Thulani; Murray Stewart, Tracy; Doering, Kim; Fraser, Alison; Casero, Robert A; Woster, Patrick M.

In: Journal of Medicinal Chemistry, Vol. 51, No. 8, 24.04.2008, p. 2447-2456.

Research output: Contribution to journalArticle

Varghese, Sheeba ; Senanayake, Thulani ; Murray Stewart, Tracy ; Doering, Kim ; Fraser, Alison ; Casero, Robert A ; Woster, Patrick M. / Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors. In: Journal of Medicinal Chemistry. 2008 ; Vol. 51, No. 8. pp. 2447-2456.
@article{d7629d5c89744f11a14a5fad2a55b2c9,
title = "Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors",
abstract = "A series of polyaminohydroxamic acids (PAHAs) and polyaminobenzamides (PABAs) were synthesized and evaluated as isoform-selective histone deacetylase (HDAC) inhibitors. These analogues contain a polyamine chain to increase affinity for chromatin and facilitate cellular import. Seven PAHAs inhibited HDAC >50{\%} (1 μM), and two PABAs inhibited HDAC >50{\%} (5 μM). Compound 17 increased acetylated α-tubulin in HCT116 colon tumor cells 253-fold but only modestly increased p21waf1 and acetylated histones 3 and 4, suggesting that 17 selectively inhibits HDAC 6. PABA 22 alone minimally increased p21waf1 and acetylated histones 3 and 4 but caused dose-dependent increases in p21waf1 in combination with 0.1 μM 5-azadeoxycytidine. Finally, 22 appeared to be a substrate for the polyamine transport system. None of these compounds were cytotoxic at 100 μM. PAHAs and PABAs exhibit strikingly different cellular effects from SAHA and have the potential for use in combination antitumor therapies with reduced toxicity.",
author = "Sheeba Varghese and Thulani Senanayake and {Murray Stewart}, Tracy and Kim Doering and Alison Fraser and Casero, {Robert A} and Woster, {Patrick M.}",
year = "2008",
month = "4",
day = "24",
doi = "10.1021/jm701384x",
language = "English (US)",
volume = "51",
pages = "2447--2456",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors

AU - Varghese, Sheeba

AU - Senanayake, Thulani

AU - Murray Stewart, Tracy

AU - Doering, Kim

AU - Fraser, Alison

AU - Casero, Robert A

AU - Woster, Patrick M.

PY - 2008/4/24

Y1 - 2008/4/24

N2 - A series of polyaminohydroxamic acids (PAHAs) and polyaminobenzamides (PABAs) were synthesized and evaluated as isoform-selective histone deacetylase (HDAC) inhibitors. These analogues contain a polyamine chain to increase affinity for chromatin and facilitate cellular import. Seven PAHAs inhibited HDAC >50% (1 μM), and two PABAs inhibited HDAC >50% (5 μM). Compound 17 increased acetylated α-tubulin in HCT116 colon tumor cells 253-fold but only modestly increased p21waf1 and acetylated histones 3 and 4, suggesting that 17 selectively inhibits HDAC 6. PABA 22 alone minimally increased p21waf1 and acetylated histones 3 and 4 but caused dose-dependent increases in p21waf1 in combination with 0.1 μM 5-azadeoxycytidine. Finally, 22 appeared to be a substrate for the polyamine transport system. None of these compounds were cytotoxic at 100 μM. PAHAs and PABAs exhibit strikingly different cellular effects from SAHA and have the potential for use in combination antitumor therapies with reduced toxicity.

AB - A series of polyaminohydroxamic acids (PAHAs) and polyaminobenzamides (PABAs) were synthesized and evaluated as isoform-selective histone deacetylase (HDAC) inhibitors. These analogues contain a polyamine chain to increase affinity for chromatin and facilitate cellular import. Seven PAHAs inhibited HDAC >50% (1 μM), and two PABAs inhibited HDAC >50% (5 μM). Compound 17 increased acetylated α-tubulin in HCT116 colon tumor cells 253-fold but only modestly increased p21waf1 and acetylated histones 3 and 4, suggesting that 17 selectively inhibits HDAC 6. PABA 22 alone minimally increased p21waf1 and acetylated histones 3 and 4 but caused dose-dependent increases in p21waf1 in combination with 0.1 μM 5-azadeoxycytidine. Finally, 22 appeared to be a substrate for the polyamine transport system. None of these compounds were cytotoxic at 100 μM. PAHAs and PABAs exhibit strikingly different cellular effects from SAHA and have the potential for use in combination antitumor therapies with reduced toxicity.

UR - http://www.scopus.com/inward/record.url?scp=43049129992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049129992&partnerID=8YFLogxK

U2 - 10.1021/jm701384x

DO - 10.1021/jm701384x

M3 - Article

C2 - 18348516

AN - SCOPUS:43049129992

VL - 51

SP - 2447

EP - 2456

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 8

ER -